Asia Pacific Pen Needles Market (2024-2029)
The Asia Pacific Pen Needles Market was valued at $26.81 Million in 2024 and projected to reach to $40.46 Million by 2029, representing a compound annual growth rate of 7.1%. The Asia Pacific pen needles market is positioned for sustained growth through 2029, supported by escalating diabetes prevalence, healthcare infrastructure improvements, and increasing patient preference for user-friendly injection devices.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific Pen Needles Market Trends and Insights
- Australia & New Zealand's healthcare infrastructure and rising diabetes prevalence are driving demand for injectable delivery devices.
- The region's aging population and increased adoption of insulin pen therapy in Australia & New Zealand are key factors supporting market expansion during the 2024–2029 forecast period. Australia & New Zealand demonstrates strong market fundamentals with a 7.1% compound annual growth rate, reflecting growing patient awareness and healthcare provider endorsement of pen needle technology.
- In Australia & New Zealand, regulatory support and reimbursement policies favor modern injection devices, creating a favorable environment for market participants.
- The competitive landscape in Australia & New Zealand includes both established medical device manufacturers and emerging players focused on safety-engineered and user-friendly needle solutions..
Key Market Statistics
- CAGR (2024-2029) 7.1% CAGR
- Market Size, 2024 ~USD 26.81 Million
- Forecast, 2029 ~USD 40.46 Million
- Geography Asia Pacific
Asia Pacific Pen Needles Market Overview
Rapid Market Expansion :
Asia Pacific pen needles market is growing at 7.1% CAGR, expanding from USD 26.81 million in 2024 to USD 40.46 million by 2029, driven by increasing diabetes prevalence and healthcare modernization across the region.
Japan & China Leadership :
Japan (USD 172.4M) and China (USD 177.63M) dominate the Asia Pacific market, accounting for the largest share due to advanced healthcare infrastructure, high diabetes incidence, and strong adoption of insulin pen therapy.
Aging Population Dynamics :
Asia Pacific's rapidly aging demographic, particularly in Japan, Australia & New Zealand, and South Korea, is significantly increasing demand for convenient injectable delivery devices and pen needle solutions.
Emerging Market Opportunities :
India (USD 21.55M) and Southeast Asia (USD 20.9M) represent high-growth opportunities with rising diabetes awareness, improving healthcare access, and increasing adoption of modern insulin delivery systems.
Asia Pacific Pen Needles Market Dynamics
- Japan and China's mature markets continue to drive regional revenue, while emerging economies in Southeast Asia and India present significant expansion opportunities.
- Healthcare providers across the region are increasingly recommending pen needle therapy due to improved patient compliance and reduced injection-related complications.
- Government healthcare initiatives and rising disposable incomes are further accelerating market penetration in developing Asia Pacific nations..
Related Ecosystem
Drug Delivery Devices
- Disposable Autoinjectors
- Reusable Autoinjectors
- Insulin Pumps
- Pen Injectors
- Transdermal Patches
- Novo nordisk a/s
- Becton, Dickinson and Company
- Terumo Corporation
- Medtronic plc
- Nipro Corporation
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Australia & New Zealand pen needles market is valued at USD 26.81 million in 2024 and expected to grow to USD 40.46 million by 2029.
- The 7.1% CAGR in Australia & New Zealand reflects strong demand driven by rising diabetes prevalence and aging demographics.
- Australia & New Zealand's supportive regulatory environment and reimbursement policies accelerate adoption of modern injection devices.
- Safety-engineered and user-friendly needle innovations are key competitive differentiators in the Australia & New Zealand market.
Pen Needles Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | SAFETY PEN NEEDLES (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 9.2% from 2024 to 2029 |
| Largest Segment | STANDARD PEN NEEDLES (Type) |
| Market Size Base Year (Billions) | ~USD 1.82 (2024) |
| Revenue Forecast (Billions) | ~USD 3.08 (2029) |
| Segments Covered | Type, Length, Application, Mode Of Purchase, Care Setting |
Asia Pacific Pen Needles Market Report Segmentation
5 segment dimensions are covered across the global market.
By Type
- Safety Pen Needles
- Standard Pen Needles
By Length
- 10Mm
- 12Mm
- 4Mm
- 5Mm
- 6Mm
- 8Mm
By Application
- Glp-1 Therapy
- Growth Hormone Therapy
- Insulin Therapy
- Osteoporosis
- Other Applications
By Mode Of Purchase
- Online Purchase
- Otc Purchase
- Other Modes Of Purchase
- Prescription-Based Purchase
By Care Setting
- Home Care Settings
- Hospitals & Clinics
- Hospitals And Clinics
- Other End Users
Target Audience
- Medical Device Manufacturers : Manufacturers need Asia Pacific market intelligence to identify growth opportunities, understand regional regulatory requirements, and develop localized product strategies for Japan, China, and emerging markets.
- Healthcare Distributors & Suppliers : Distributors require detailed country-level market data to optimize inventory management, identify high-growth regions, and establish partnerships with healthcare providers across Asia Pacific.
- Pharmaceutical Companies : Pharma firms need insights into insulin pen adoption rates and diabetes management trends across Asia Pacific to align their injectable drug delivery strategies with regional market demands.
- Healthcare Investors & PE Firms : Investors need comprehensive market analysis, growth projections, and competitive landscape data to evaluate investment opportunities in Asia Pacific's expanding pen needle and diabetes care sectors.
- Healthcare Policy & Government Bodies : Government agencies and health ministries require market data to inform diabetes management policies, healthcare infrastructure planning, and reimbursement strategies across Asia Pacific regions.
Key Companies in the Asia Pacific Pen Needles Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Injectable and infusion-based delivery in LTAC hospitals,Oral drug administration in inpatient rehabilitation facilities,Contract rehabilitation and outpatient-related drug administration support, |
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Lifecycle services and digital/connected factory solutions,Contract manufacturing and value-added integration, |
| ALLERGAN PLC | Ireland | Private Company | Medical Aesthetics & Dermatology,Eye Care,Neuroscience & CNS, |
| CONSORT MEDICAL | United Kingdom | Private Company | Inhalation delivery devices,Injectable and autoinjector devices,Nasal and other specialty devices, |
| HENRY SCHEIN | United States | Public Company | Global Distribution & Value-Added Services,Global Specialty Products,Global Technology, |
| EMBECTA CORP. | United States | Public Company | Pen needles,Syringes,Safety injection devices, |
| NOVO NORDISK A/S | Denmark | Public Company | GLP-1 for Diabetes (injectable and oral),Obesity Care (GLP-1, including Wegovy pill),Insulin and Smart Pens (NovoPen 6, Echo Plus, needles), |
| YPSOMED | Switzerland | Public Company | Pen injectors,Auto-injectors,Wearable injectors and patch pumps, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| NIPRO | Japan | Public Company | Dialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceutical-related (generics, kits, CDMO for injectables and oral drugs), |
| ARKRAY, INC. | Japan | Private Company | Diabetes testing & blood glucose monitoring,Urinalysis,Immunodiagnostics, |
| HTL-STREFA | Poland | Private Company | Safety lancets for professional capillary sampling,Personal lancets for home blood glucose monitoring,Pen needles for diabetes therapy, |
| BERPU MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | Regular insulin pen needles,Safety insulin pen needles and pens,Hypodermic and hypo-dermal needles, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates with 64,200 employees. The company provides healthcare services and related solutions across the United States.
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ALLERGAN PLC
Allergan PLC is an Ireland-based private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and medical aesthetics sectors.
CONSORT MEDICAL
Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees. The company provides medical device and pharmaceutical delivery solutions.
HENRY SCHEIN
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to medical, dental, and veterinary professionals.
EMBECTA CORP.
Embecta Corp. is a United States-based public company founded in 1924 with 1,850 employees. The company manufactures and distributes diabetes care and medical devices.
NOVO NORDISK A/S
Novo Nordisk A/S is a Denmark-based public company founded in 1923 with 67,900 employees. The company is a global pharmaceutical company specializing in diabetes, obesity, and other chronic diseases.
YPSOMED
Ypsomed is a Switzerland-based public company founded in 1984 with 2,025 employees. The company develops and manufactures injection and infusion systems for diabetes and other therapeutic areas.
TERUMO CORPORATION
Terumo Corporation is a Japan-based public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices, blood products, and pharmaceutical solutions globally.
NIPRO
Nipro is a Japan-based public company founded in 1947 with 38,593 employees. The company manufactures and supplies medical devices, pharmaceuticals, and healthcare products worldwide.
ARKRAY, INC.
Arkray, Inc. is a Japan-based private company founded in 1960 with 566 employees. The company manufactures diagnostic and medical devices for healthcare applications.
HTL-STREFA
HTL-Strefa is a Poland-based private company founded in 2000. The company manufactures medical devices and related healthcare products.
BERPU MEDICAL TECHNOLOGY CO., LTD.
Berpu Medical Technology Co., Ltd. is a China-based private company founded in 2000. The company manufactures medical devices and related healthcare solutions.
Countries within Asia Pacific - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Japan | USD 172.4 Million |
| China | USD 177.63 Million |
| India | USD 21.55 Million |
| South Korea | USD 6.85 Million |
| Australia & New Zealand | USD 4.7 Million |
| Southeast Asia | USD 20.9 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Segmentation : Gain detailed insights into Asia Pacific's diverse markets including Japan, China, India, and Southeast Asia with country-specific data, growth drivers, and competitive landscapes tailored to regional dynamics.
- Growth Opportunity Identification : Identify high-potential emerging markets in Southeast Asia and India where diabetes prevalence is rising and healthcare infrastructure is rapidly improving, offering significant expansion opportunities.
- Competitive Intelligence : Understand competitive positioning across Asia Pacific's key markets, including market leaders in Japan and China, and emerging players in developing regions to inform strategic planning.
- Demographic & Healthcare Trends : Access comprehensive analysis of aging populations, rising diabetes incidence, healthcare modernization, and government initiatives driving pen needle adoption across Asia Pacific nations.
- Strategic Market Entry Planning : Leverage country-specific market size data, CAGR projections, and regional insights to develop targeted market entry strategies and investment decisions for Asia Pacific expansion.
Frequently asked questions
What is the current market size of pen needles in Australia & New Zealand?
The pen needles market in Australia & New Zealand was valued at USD 26.81 million in 2024.
What is the projected market size for pen needles in Australia & New Zealand by 2029?
Australia & New Zealand's pen needles market is forecast to reach USD 40.46 million by 2029.
What is the CAGR for the pen needles market in Australia & New Zealand?
The pen needles market in Australia & New Zealand is expected to grow at a compound annual growth rate of 7.1% from 2024 to 2029.
What factors are driving growth in the Australia & New Zealand pen needles market?
Key growth drivers in Australia & New Zealand include rising diabetes prevalence, an aging population, increased adoption of insulin pen therapy, and supportive regulatory policies.
Who are the main competitors in the Australia & New Zealand pen needles market?
The Australia & New Zealand market includes established medical device manufacturers and emerging players focused on safety-engineered and user-friendly needle solutions.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the pen needles market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the pen needles market. Primary sources from the demand side included hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.
A breakdown of the primary respondents for pen needles market (supply side) market is provided below:
Note 1: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 3: Other primaries include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size for pen needles market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for pen needles market was calculated using data from three distinct sources, as will be discussed below:
Data Triangulation
The entire market was split up into five segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.
Approach to derive the market size and estimate market growth.
Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of pen needles. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
A pen needle is a hollow needle entrenched in a plastic hub and attached to injectable pens. Pen needles are available in a wide range of lengths and diameters and can be used by healthcare professionals and patients to deliver injectable medications into the patient’s body. Pen needles are electro-polished for smooth, thin, and fine-point tips and provide comfort and ease in penetration; they serve as an alternative drug delivery technique to the traditional method of injecting drugs.
Stakeholders
- Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Original equipment manufacturing companies
- Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Healthcare service providers
- Teaching hospitals and academic medical centers
- Health insurance players
- Government bodies/municipal corporations
- Regulatory bodies
- Business research and consulting service providers
- Authorities framing reimbursement policies for pen needles
- Venture capitalists
- Market research and consulting firms
Report Objectives
- To define, describe, and forecast the pen needles market based on type, length, application, mode of purchase, setting and region.
- To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall pen needles market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the pen needles market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa and GCC Countries
- To profile the key players and comprehensively analyze their market shares and core competencies in the pen needles market
- To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the pen needles market
- To benchmark players within the pen needles market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings.
Get the Full Pen Needles Market Report
Full forecast, segment splits, and company analysis for all Pen Needles Market.
- Canada Pen Needles Market
- US Pen Needles Market
- Germany Pen Needles Market
- UK Pen Needles Market
- France Pen Needles Market
- Italy Pen Needles Market
- Spain Pen Needles Market
- Japan Pen Needles Market
- China Pen Needles Market
- India Pen Needles Market
- South Korea Pen Needles Market
- Brazil Pen Needles Market
- Mexico Pen Needles Market
- Argentina Pen Needles Market
- GCC Countries Pen Needles Market
- Rest Of Europe Pen Needles Market
- Rest Of Asia Pacific Pen Needles Market
- Southeast Asia Pen Needles Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
